An 18-month-old girl is brought to the pediatrician’s office for failure to thrive and developmental delay. The patient’s mother says she has not started speaking and is just now starting to pull herself up to standing position. Furthermore, her movement appears to be restricted. Physical examination reveals coarse facial features and restricted joint mobility. Laboratory studies show increased plasma levels of several enzymes. Which of the following is the underlying biochemical defect in this patient?

Failure of mannose phosphorylation

Congenital lack of lysosomal formation

Inappropriate protein targeting to endoplasmic reticulum

Inappropriate degradation of lysosomal enzymes

An investigator is studying the function of the endoplasmic reticulum in genetically modified lymphocytes. A gene is removed that facilitates the binding of ribosomes to the endoplasmic reticulum. Which of the following processes is most likely to be impaired as a result of this genetic modification?

Production of secretory proteins

An experimental compound added to a protein disrupts both alpha helices as well as beta-pleated sheets. Which of the following has the experimental compound affected?

Hydrogen bonds between amino acids

Ionic bonds between amino acids

Covalent peptide bonds between amino acids

Disulfide bonds between amino acids

The primary structure of the protein

A 3-year-old is brought to the pediatrician by his mother because she is concerned about recent changes to his behavior. She states that he has seemed to regress in his motor development and has been having occasional brief episodes of uncontrollable shaking. During the subsequent work up, a muscle biopsy is obtained which demonstrates red ragged fibers and a presumptive diagnosis of a genetic disease made. The mother asks if her other son will be affected. What should be the physician's response?

There is a 100% chance he will be affected, but the severity may be different

There is a 50% chance he will be affected

There is a 100% chance he will be affected, and the severity will be the same

There is a 25% chance he will be affected

A 9-year-old boy is brought to his primary care physician after his mom noticed that he was limping. He says that he has been experiencing significant hip and knee pain over the last 2 months but thought he may have just strained a muscle. Radiographs show a collapse of the femoral head, and he is diagnosed with Legg-Calve-Perthes disease. He undergoes surgery and is placed in a Petrie cast from his hips to his toes bilaterally so that he is unable to move his knees or ankles. Eight weeks later, the cast is removed, and he is found to have significantly smaller calves than before the cast was placed. Which process in myocytes is most likely responsible for this finding?

Decreased formation of double membrane bound vesicles

Increased formation of double membrane bound vesicles

Inhibition of gene transcription

A 67-year-old man comes to the physician for a follow-up examination after he was diagnosed with mantle cell lymphoma. The physician recommends a chemotherapeutic regimen containing bortezomib. Which of the following best describes the effect of this drug?

Accumulation of ubiquitinated proteins

Preventing the relaxation of DNA supercoils

Inhibition of tyrosine kinase receptors

Stabilization of tubulin polymers

A 12-year-old male presents to the emergency department following several days of facial edema. A urinalysis confirms proteinuria and hematuria. Once admitted, a kidney biopsy is viewed under an electron microscope to confirm the diagnosis of minimal change disease. In the following electron micrograph, what process occurs in the structure marked with an arrow?

Podocyte foot process effacement

Normal podocyte foot process interdigitation

Glomerular basement membrane thickening

An 8-month-old female infant from a first-degree consanguineous couple was brought to the physician because the mother noticed abnormalities in the growth of her child as well as the different lengths of her child's legs. The infant had gingival hyperplasia, restricted movement in both shoulders, a prominent, pointed forehead, and enophthalmos with a slight opacity in both corneas. A blood test revealed 10 fold higher than normal levels of the following enzymes: N-acetyl-ß-glucosaminidase, ß-glucuronidase, ß-hexosaminidase A, and alkaline phosphatase. Which of the following is most likely deficient in this patient?

N-acetyl-glucosamine-1-phosphotransferase

Lysosomal alpha-1,4-glucosidase

Glucose-6-phosphate dehydrogenase

Post-translational modifications for USMLE Step 1: High-Yield Biochemistry Lessons

PTM Basics - Protein Finishing School

Post-translational modifications of a target protein

What? Covalent modification of proteins after translation, diversifying function & regulating activity.
Where? Endoplasmic Reticulum, Golgi apparatus, cytoplasm.
Key Modifications:
- Phosphorylation: On Ser, Thr, Tyr residues via kinases. Reversible.
- Glycosylation: N-linked (Asn, in RER) & O-linked (Ser/Thr, in Golgi).
- Ubiquitination: Targets proteins for proteasomal degradation.
- Acetylation/Methylation: Modifies histones, regulating gene access.
- Hydroxylation: Proline/Lysine in collagen; requires Vitamin C.

⭐ I-cell disease results from failed mannose-6-phosphate tagging of lysosomal proteins, causing them to be secreted. Features include coarse facies & skeletal defects.

Key Modifications - Molecular Tagging

Ubiquitination: Covalent attachment of ubiquitin (a 76-amino acid polypeptide) to target proteins, primarily marking them for degradation.
- Function: Acts as a molecular "tag" for destruction by the proteasome. Also involved in DNA repair and signal transduction.
- Mechanism: A three-enzyme cascade:
  - E1 (Activating Enzyme): Activates ubiquitin via ATP.
  - E2 (Conjugating Enzyme): Carries the activated ubiquitin.
  - E3 (Ligase): Recognizes the specific protein substrate and transfers ubiquitin to it. Determines substrate specificity.

⭐ Proteasome inhibitors (e.g., Bortezomib, Carfilzomib) are key drugs for multiple myeloma. By blocking the proteasome, they cause an accumulation of toxic, misfolded proteins within malignant plasma cells, triggering apoptosis.

SUMOylation: Attachment of a Small Ubiquitin-like Modifier (SUMO).
- Function: Alters protein function, localization, and protein-protein interactions. It does not tag for degradation.

Ubiquitin-proteasome pathway diagram

Clinical Focus - When PTMs Go Wrong

Defective PTMs disrupt protein structure, function, and localization, leading to numerous diseases.
Glycosylation Errors
- I-Cell Disease (Mucolipidosis II): Failure of Golgi to add mannose-6-phosphate tag to lysosomal enzymes. Proteins are secreted extracellularly instead of trafficked to the lysosome.
  - Presents with coarse facial features, skeletal abnormalities, clouded corneas.
Hydroxylation Defects
- Scurvy: Vitamin C (ascorbate) deficiency impairs prolyl & lysyl hydroxylases, leading to defective collagen synthesis.
- Ehlers-Danlos Syndrome (some types): Lysyl hydroxylase deficiency causes unstable collagen, leading to joint hypermobility.
Abnormal Phosphorylation
- Alzheimer's Disease: Hyperphosphorylation of tau protein leads to neurofibrillary tangles and neuronal death.

Lysosomal enzyme trafficking and M6P modification

⭐ In I-cell disease, the diagnostic hallmark is high plasma levels of lysosomal enzymes, which are secreted from the cell due to the failed mannose-6-phosphate targeting signal.

High‑Yield Points - ⚡ Biggest Takeaways

Trimming of propeptides is crucial for activating zymogens (e.g., trypsinogen).

Phosphorylation by kinases and dephosphorylation by phosphatases are key regulatory switches.

Glycosylation (N-linked in the ER, O-linked in the Golgi) is vital for protein targeting and stability.

Hydroxylation of proline and lysine in collagen synthesis requires vitamin C.

Ubiquitination tags proteins for degradation by the proteasome.

Disulfide bonds between cysteine residues stabilize extracellular proteins like insulin.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play